Securities code: Guobang Pharma Ltd(605507) securities abbreviation: Guobang Pharma Ltd(605507) Announcement No.: 2022003 Guobang Pharma Ltd(605507)
About using part of the temporarily idle raised funds for cash management
Announcement of due redemption
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Guobang Pharma Ltd(605507) (hereinafter referred to as “the company”) held the 10th meeting of the first board of directors and the 6th meeting of the first board of supervisors on August 13, 2021, deliberated and approved the proposal on using part of the temporarily idle raised funds for cash management, and agreed that the company and its subsidiaries use the temporarily idle raised funds of no more than RMB 1.2 billion for cash management, It is used to purchase principal guaranteed financial products with high security, good liquidity and single product investment period of no more than 12 months, which can be used on a rolling basis within the validity period of the resolution. The independent directors and the board of supervisors of the company have expressed clear consent to the proposal, and the recommendation institution has issued verification opinions on this matter. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on August 14, 2021 And the announcement of Guobang Pharma Ltd(605507) on cash management with some temporarily idle raised funds (Announcement No.: 2021005) disclosed by the information disclosure media designated by the company.
1、 Due redemption of this financial product
On September 1, 2021, the company purchased Industrial And Commercial Bank Of China Limited(601398) linked exchange rate range cumulative corporate RMB structured deposit product – special account type, phase 257, T payment in 2021 of RMB 200 million from Industrial And Commercial Bank Of China Limited(601398) Co., Ltd, For details, please refer to the announcement of Guobang Pharma Ltd(605507) on the progress of cash management using some temporarily idle raised funds (Announcement No.: 2021013) disclosed by the company on the website of Shanghai Stock Exchange on September 2, 2021. The above financial products have been redeemed at maturity, the principal has been recovered by 200 million yuan, and the financial income has been obtained by 3.0344 million yuan.
2、 As of the date of this announcement, the company’s cash management of raised funds in the last 12 months
Unit: 10000 yuan
No. financial product type actual investment amount actual principal recovered actual income outstanding principal amount
1 bank financial products 2 Qingdao Tgood Electric Co.Ltd(300001) 5 Shenzhen Properties & Resources Development (Group) Ltd(000011) 29.6380000
Total 2 Qingdao Tgood Electric Co.Ltd(300001) 5 Shenzhen Properties & Resources Development (Group) Ltd(000011) 29.6380000
The maximum amount invested in a single day in the last 12 months is 50000
Maximum daily investment amount in the last 12 months / net assets of the last year (%) 15.27
Cumulative income from cash management in the last 12 months / net profit of the last year (%) 1.39
The cash management limit used at present is 80000
Unused cash management limit 40000
Total cash management limit 120000
Note: if the total number in the table is inconsistent with the mantissa of the sum of the sub item values, it is due to rounding. It is hereby announced.
Guobang Pharma Ltd(605507) board of directors March 9, 2022
